Will it play in Peoria?
SM Grunberg
JCO May 1 1991: 713–715. [PDF]
Levamisole as adjuvant therapy for melanoma: quo vadis?
DR Parkinson
JCO May 1 1991: 716–717. [PDF]
Needed: clinical trials for older patients
BJ Kennedy
JCO May 1 1991: 718–720. [PDF]
	A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy
	J Hainsworth, W Harvey, K Pendergrass, B Kasimis, D Oblon, G Monaghan, D Gandara, P Hesketh, A Khojasteh, and G Harker
	JCO May 1 1991: 721–728. [Abstract] [PDF]
	Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group
	IC Quirt, WE Shelley, JL Pater, AJ Bodurtha, PB McCulloch, TA McPherson, AH Paterson, R Prentice, HK Silver, and AR Willan
	JCO May 1 1991: 729–735. [Abstract] [PDF]
	A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma
	LE Spitler
	JCO May 1 1991: 736–740. [Abstract] [PDF]
	Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma
	SE O'Reilly, P Klimo, and JM Connors
	JCO May 1 1991: 741–747. [Abstract] [PDF]
	Combination chemotherapy of intermediate-grade and high-grade non- Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study
	JK Weick, S Dahlberg, RI Fisher, B Dana, TP Miller, SP Balcerzak, and HI Pierce
	JCO May 1 1991: 748–753. [Abstract] [PDF]
	Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease
	RT Silver, DC Case, Jr, RH Wheeler, TP Miller, RS Stein, JJ Stuart, BA Peterson, SE Rivkin, HM Golomb, and Costanzi
	JCO May 1 1991: 754–761. [Abstract] [PDF]
	Multivariate analysis of prognostic factors in stage IV follicular low- grade lymphoma: a risk model
	JE Romaguera, P McLaughlin, L North, D Dixon, KB Silvermintz, LA Garnsey, WS Velasquez, FB Hagemeister, and F Cabanillas
	JCO May 1 1991: 762–769. [Abstract] [PDF]
	Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial
	B Raphael, JW Andersen, R Silber, M Oken, D Moore, J Bennett, H Bonner, R Hahn, WH Knospe, and J Mazza
	JCO May 1 1991: 770–776. [Abstract] [PDF]
	Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study
	J Ochs, ML Brecher, D Mahoney, R Vega, BH Pollock, GR Buchanan, VM Whitehead, Y Ravindranath, and AI Freeman
	JCO May 1 1991: 777–782. [Abstract] [PDF]
	Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors
	J Allen, R Packer, A Bleyer, P Zeltzer, M Prados, and A Nirenberg
	JCO May 1 1991: 783–788. [Abstract] [PDF]
	Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma
	RP Castleberry, LE Kun, JJ Shuster, G Altshuler, IE Smith, R Nitschke, M Wharam, N McWilliams, V Joshi, and FA Hayes
	JCO May 1 1991: 789–795. [Abstract] [PDF]
	Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study
	JA Ortega, M Wharam, EA Gehan, AH Ragab, W Crist, B Webber, ES Wiener, V Haeberlen, and HM Maurer
	JCO May 1 1991: 796–801. [Abstract] [PDF]
	Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma [published erratum appears in J Clin Oncol 1992 Feb;10(2):346]
	DT Scadden, HA Bering, JD Levine, J Bresnahan, L Evans, C Epstein, and JE Groopman
	JCO May 1 1991: 802–808. [Abstract] [PDF]
	Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer
	U Beller, J Speyer, N Colombo, J Sorich, J Wernz, H Hochster, A Zeleniuch- Jacquotte, R Porges, and EM Beckman
	JCO May 1 1991: 809–817. [Abstract] [PDF]
	Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
	N Aass, O Klepp, E Cavallin-Stahl, O Dahl, H Wicklund, B Unsgaard, L Baldetorp, S Ahlstrom, and SD Fossa
	JCO May 1 1991: 818–826. [Abstract] [PDF]
	Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group
	JA Wils, HO Klein, DJ Wagener, H Bleiberg, H Reis, F Korsten, T Conroy, M Fickers, S Leyvraz, and M Buyse
	JCO May 1 1991: 827–831. [Abstract] [PDF]
	Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases
	JA Neidhart, SA Anderson, JE Harris, JJ Rinehart, J Laszlo, FH Dexeus, LH Einhorn, DL Trump, PW Benedetto, and RL Tuttle
	JCO May 1 1991: 832–836. [Abstract] [PDF]
	Routine imaging studies for the posttreatment surveillance of breast and colorectal carcinoma
	AR Kagan and RJ Steckel
	JCO May 1 1991: 837–842. [Abstract] [PDF]
	Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma
	CG Willett, PC Shellito, JE Tepper, R Eliseo, K Convery, and WC Wood
	JCO May 1 1991: 843–849. [Abstract] [PDF]
	Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer
	DG Pfister, E Strong, L Harrison, IE Haines, DA Pfister, R Sessions, R Spiro, J Shah, F Gerold, and T McLure
	JCO May 1 1991: 850–859. [Abstract] [PDF]
	Intravenous carboplatin for recurrent malignant glioma: a phase II study
	WK Yung, L Mechtler, and MJ Gleason
	JCO May 1 1991: 860–864. [Abstract] [PDF]
	Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial
	M Attal, D Schlaifer, H Rubie, F Huguet, JP Charlet, E Bloom, J Lemozy, P Massip, J Pris, and G Laurent
	JCO May 1 1991: 865–870. [Abstract] [PDF]
	Limited sampling models for doxorubicin pharmacokinetics
	MJ Ratain, J Robert, and WJ van der Vijgh
	JCO May 1 1991: 871–876. [Abstract] [PDF]
	Wilms' tumor: status report, 1990. By the National Wilms' Tumor Study Committee
	JCO May 1 1991: 877–887. [Abstract] [PDF]
A clinical phase II study of ProMACE-CytaBOM
S Dahlberg, TP Miller, and RI Fisher
JCO May 1 1991: 888a. [PDF]
Efficacy of intraportal infusion for colon cancer: a fair assessment?
S Marsoni, V Torri, A Taiana, A Liberati, R Labianca, G Pancera, R Gray, and M Clarke
JCO May 1 1991: 888b–889. [PDF]
The impact of doxorubicin dose intensity on survival of patients with Ewing's sarcoma
MA Smith
JCO May 1 1991: 889–891. [PDF]
Publication of unethical studies on the treatment of chemotherapy- induced emesis
F Roila, M Tonato, and A Del Favero
JCO May 1 1991: 891–893. [PDF]
Drug interaction between alpha interferon and erythropoietin
RG Desai
JCO May 1 1991: 893. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.